MedPath

IUD Insertion During Cesarean Section

Not Applicable
Completed
Conditions
Contraception
Interventions
Device: IUD during CS
Device: IUD after puerperium
Registration Number
NCT03492034
Lead Sponsor
Ain Shams University
Brief Summary

Insertion of Intrauterine Contraceptive Device during Cesarean Section: Randomized Clinical Trial

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
200
Inclusion Criteria
  1. Pregnant woman aged between 18 to 40 years old.
  2. Scheduled for elective cesarean section at gestational age between 37 to 42 weeks.
  3. Body mass index between 19-30 kg/m2
  4. Seeking contraception after delivery.
Read More
Exclusion Criteria
  1. History of menorrhagia or severe dysmenorrhea.
  2. History of pelvic inflammatory disease or current pelvic infection (ex: puerperal sepsis, purulent cervicitis).
  3. Patients who have bleeding disorders.
  4. Anemia (Hb < 9 g %).
  5. Chronic depilating diseases reducing immunity such as Diabetes.
  6. Structural uterine anomaly or large uterine fibroids distorting anatomy.
  7. History of previous IUD expulsion or removal for complications.
  8. Unexplained uterine bleeding.
  9. Copper allergy or Wilson disease.
  10. Gestational trophoblastic disease with persistently elevated Beta HCG.
  11. Predisposing factor to postoperative infection (e.g. rupture of membranes prior to admission or delivery of a stillborn baby at cesarean section).
  12. Complications during cesarean section e.g. postpartum hemorrhage.
  13. Cesarean section during placenta previa.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IUD during CSIUD during CS-
IUD after puerperiumIUD after puerperium-
Primary Outcome Measures
NameTimeMethod
IUD expulsion rate6 weeks
Secondary Outcome Measures
NameTimeMethod
Bleeding6 weeks

number of pads changed per day

Degree of Pain6 weeks

Visual Analogue Scale from 1 to10 (0 being no pain and 10 maximum pain tolerated)

dyspareunia6 weeks

Visual Analogue Scale from 0 to10 (0 being no pain and 10 maximum pain tolerated)

patient satisfaction6 weeks

Visual Analogue Scale from 0 to10 (0 being maximum dis-satisfaction and 10 maximum satisfaction)

Trial Locations

Locations (1)

Ain Shams University Maternity Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath